Labiotech.eu

News and Trends 4 Jun 2018

British Company Gets a $100M Boost to Develop a Surgical Robotic Arm

CMR Surgical has raised an impressive Series B round to develop a robotic arm to help during surgery that mirrors the movement of a human arm. CMR Surgical, based in Cambridge, UK, has raised $100M (€85M) in Series B funding to bring its surgical robot technology closer to a market launch in Europe and the US. […]

June 4, 2018 - 2 minutesmins - By Alexander Burik

Interview 4 Jun 2018

Meet the German Biotech Behind Adidas’ Biodegradable Shoes

The synbio company AMSilk is drawing inspiration from nature to produce sustainable materials for applications ranging from clothing to medicine. I spoke to CEO Jens Klein to find out more about the innovative biodegradable material that has caught Adidas’ eye. In 2016, Adidas showed the world the first prototype of a new running shoe that, […]

June 4, 2018 - 5 minutesmins - By Clara Rodríguez Fernández

News and Trends 1 Jun 2018

FDA Puts Clinical Trial for CRISPR Therapy on Hold

The FDA has put a hold on CRISPR Therapeutics’ planned Phase I/II trial testing a CRISPR gene-editing therapy in patients with sickle cell disease, which will likely delay the use of CRISPR-based therapies in humans. CRISPR Therapeutics, headquartered in Basel, Switzerland, and its partner Vertex Pharmaceuticals will have to postpone their plans to start a Phase I/II trial […]

June 1, 2018 - 2 minutesmins - By Alexander Burik

Startup Scout 1 Jun 2018

This Dutch Biotech Gets Inspiration From Snake Venom to Restore Blood Clotting

This week we’re in Leiden, the Netherlands, visiting VarmX. The biotech develops therapeutic proteins based on a peptide found in snake venom to restore blood clotting in patients with acute bleeding. Mission: Founded in 2016 as a spin-out from the University of Leiden, VarmX aims to restore blood clotting in patients with acute, internal bleeding after taking […]

June 1, 2018 - 2 minutesmins - By Alexander Burik

Grapevine Fungus Nanoparticle Technology

More News! 31 May 2018

A Trojan Horse of Nanoparticles Could Fight Fungal Infections in Grapevines

German researchers have developed nanoparticles that can protect grapevines from a fungal disease that causes great financial damage to winegrowers each year. A research team at the University of Mainz, led by Frederik Wurm, has developed a nanotechnology that can protect and heal grapevines from infestation by the fungal disease Esca. The technology is made of […]

May 31, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 31 May 2018

UK Biotech Wins Major Grant to Manage Chronic Pain With Antibodies

Innovate UK has awarded a grant to Iontas to develop antibodies that block pain transmission by nerve cells in patients with chronic pain. Iontas, based in Cambridge, has been awarded a grant of £556K (€633K) from Innovate UK to develop its antibody platform, KnotBody, for therapeutic applications in chronic pain management. Iontas’ antibody approach could provide […]

May 31, 2018 - 2 minutesmins - By Alexander Burik

Interview 30 May 2018

How to Close a €3.9B Acquisition Deal for Your Biotech Company

Ablynx, one of the big giants in the European biotech arena, closed the final stages of its €3.9B acquisition deal with Sanofi earlier this month, after details were announced in January. Edwin Moses, CEO of Ablynx, shared the company’s success story with attendees at our recent Refresh Meetup in Brussels. The technology behind Ablynx’s success […]

May 30, 2018 - 7 minutesmins - By Helen Albert

News and Trends 30 May 2018

Biotech in Germany Celebrates the Closing of a €300M Fund

High-Tech Gründerfonds (HTGF), a VC with a long track of biotech investments in Germany, has closed a new fund could benefit the country’s biotech scene. High-Tech Gründerfonds is a German VC that provides seed funding to high-tech startups, including several in the biotech space. The firm has now announced the final closing of a third […]

May 30, 2018 - 1 minutemin - By Clara Rodríguez Fernández

DBV Technologies Immunotherapy Milk Allergy

News and Trends 29 May 2018

This Immunotherapy Could Be The First to Treat Milk Allergy in Children

DBV Technologies has shown in a Phase II trial that its skin patch could desensitize over 60% of children with strong milk allergy. DBV Technologies, one of the largest public biotechs in France, is developing a skin patch technology to treat several forms of food allergies. The company has released new, promising data on its milk […]

May 29, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 29 May 2018

Positive House Dust Mite Immunotherapy Results for UK Biotech

British biotech Allergy Therapeutics reports positive early-stage results for its house dust mite immunotherapy. It’s been a good month for Allergy Therapeutics, which also reported positive Phase II results for its grass pollen allergy vaccine trial last week. It seems to be doing well, with a number of products targeting common allergies in late stage […]

May 29, 2018 - 1 minutemin - By Helen Albert

In Depth 29 May 2018

Clinical Trials in Alzheimer’s Disease Are Failing: What Can Be Done?

With no drugs that can stop the progression of the disease and hundreds of clinical trials failing, new fields of research bring hope to people with Alzheimer’s. As the Western population ages, Alzheimer’s disease is becoming one of the biggest diseases of the 21st century. But despite the efforts of science, the FDA and EMA […]

May 29, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

News and Trends 28 May 2018

Genmab and Janssen Suffer Combination Therapy Setback

Janssen will discontinue a Phase I study testing Danish biotech Genmab’s blood cancer blockbuster daratumumab combined with a candidate checkpoint inhibitor in patients with multiple myeloma. Janssen, which obtained the exclusive global rights to commercialize daratumumab from Genmab in 2012, will also discontinue a Phase Ib/II study of daratumumab in patients with non-small cell lung […]

May 28, 2018 - 2 minutesmins - By Alexander Burik

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

British Company Gets a $100M Boost to Develop a Surgical Robotic Arm

Meet the German Biotech Behind Adidas’ Biodegradable Shoes

FDA Puts Clinical Trial for CRISPR Therapy on Hold

This Dutch Biotech Gets Inspiration From Snake Venom to Restore Blood Clotting

A Trojan Horse of Nanoparticles Could Fight Fungal Infections in Grapevines

UK Biotech Wins Major Grant to Manage Chronic Pain With Antibodies

How to Close a €3.9B Acquisition Deal for Your Biotech Company

Biotech in Germany Celebrates the Closing of a €300M Fund

This Immunotherapy Could Be The First to Treat Milk Allergy in Children

Positive House Dust Mite Immunotherapy Results for UK Biotech

Clinical Trials in Alzheimer’s Disease Are Failing: What Can Be Done?

Genmab and Janssen Suffer Combination Therapy Setback

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!